Wu Qin’s approach to making the company stronger

In August 1996, Wu Qin served as the factory director and later became the chairman of Lijun Group, but his progress did not stop. He led Lijun Group to carry out technological innovation, product innovation, management innovation and cultural innovation on the basis of marketing innovation, forming a virtuous cycle in which new products are continuously launched and new economic growth points are constantly emerging.

Some people say that Wu Qin likes to quote numbers, and the following numbers prove the development and growth of Lijun Group: During the "Ninth Five-Year Plan" period, 21 new product development projects were completed, including 10 Obtained national new drug certificates and obtained production approval numbers for 26 items. "Lijunsha", "Limaxian", "Lexiding" and "Paiqi" ??won the title of "National Key New Products", and "Dobes" and "Lexiding" entered the National Spark Plan project. Innovation lays the foundation for enterprise development and establishes the driving force for sustainable development. Lijun Group adopts the development model of "group operating assets and enterprise operating products" and has acquired a number of advantageous enterprises under Lijun through holding, shareholding and mergers. Last year, Lijun Group invested another 10 million yuan to control Weinan Hengxintang Pharmaceutical and established the company's modern traditional Chinese medicine production base.

While the company is developing, Wu Qin cares more about his employees. He first launched the "Lijun Enterprise is My Home" campaign in the company, and then actively promoted employee stock ownership allocation, so that employees can truly "workers have their own shares." The per capita income in Lijun is now more than twice that of Shaanxi Province, and the per capita housing area has also increased by 2.1 times.